New Anticancer Agents: Recent Developments in Tumor Therapy

被引:1
作者
Ali, Riyasat [2 ]
Mirza, Zeenat [1 ]
Ashraf, Ghulam M. D. [1 ]
Kamal, Mohammad Amjad [1 ]
Ansari, Shakeel Ahmed [3 ]
Damanhouri, Ghazi Abdullah [1 ]
Abuzenadah, Adel Mohammad [1 ]
Chaudhary, Adeel Ga [1 ]
Sheikh, Ishfaq Ahmed [1 ]
机构
[1] King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah 21589, Saudi Arabia
[2] All India Inst Med Sci, Dept Biochem, New Delhi 110029, India
[3] King Abdulaziz Univ, Ctr Excellence Genom Med Res, Jeddah 21589, Saudi Arabia
关键词
Natural products; plant-derived chemicals; new anticancer agents; review; HUMAN PROSTATE-CANCER; ACTIVATED PROTEIN-KINASES; GREEN TEA POLYPHENOL; NF-KAPPA-B; IN-VITRO; EPIGALLOCATECHIN GALLATE; CELL-PROLIFERATION; SIGNALING PATHWAYS; ANTITUMOR-ACTIVITY; YUCCA-SCHIDIGERA;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Increasing recurrence of mammalian tumors and severe side-effects of chemotherapeutic agents reduce the clinical efficacy of a large variety of anticancer agents that are currently being used. Thus, there is always a constant need to develop alternative or synergistic anticancer drugs with minimal side-effects. One important strategy to develop effective anticancer agents is to study into anticancer agents derived from natural sources. Anticancer agents derived from plants and their derivatives have been proven to be effective for cancer prevention and therapeutics. Vinca alkaloid and their derivatives, alone and in combination with therapeutic agents, have been used for a long time for the treatment of various types of cancers. Polyphenols form one of the most important and extensively used classes of plant-derived therapeutics for cancer prevention or chemotherapy. The present review highlights a plethora of studies focused on the antineoplastic properties of plant-derived chemicals, such as Vinca alkaloid, saponins, and flavonoids.
引用
收藏
页码:2999 / 3005
页数:7
相关论文
共 97 条
[81]   Cancer chemoprevention with dietary phytochemicals [J].
Surh, YJ .
NATURE REVIEWS CANCER, 2003, 3 (10) :768-780
[82]  
Surh YJ, 2008, ASIA PAC J CLIN NUTR, V17, P269
[83]   KINETIC STABILIZATION OF MICROTUBULE DYNAMIC INSTABILITY INVITRO BY VINBLASTINE [J].
TOSO, RJ ;
JORDAN, MA ;
FARRELL, KW ;
MATSUMOTO, B ;
WILSON, L .
BIOCHEMISTRY, 1993, 32 (05) :1285-1293
[84]   Phase I and Pharmacokinetic Study of IV Vinflunine in Combination with Gemcitabine for Treatment of Advanced Non-small Cell Lung Cancer in Chemonaive Patients [J].
Tournoux-Facon, Caroline ;
Senellart, Helene ;
Lemarie, Etienne ;
Tourani, Jean Marc ;
Favrel, Stephanie ;
Pouget, Jean Christophe ;
Pinel, Marie Claire ;
Bennouna, Jaafar .
JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (07) :1247-1253
[85]   Cytotoxic labdane alkaloids from an ascidian Lissoclinum sp.:: Isolation, structure elucidation, and structure-activity relationship [J].
Uddin, Jasim ;
Ueda, Katsuhiro ;
Siwu, Eric R. O. ;
Kita, Masaki ;
Uemura, Daisuke .
BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (20) :6954-6961
[86]   Haterumaimides F-I, four new cytotoxic diterpene alkaloids from an ascidian Lissoclinum species [J].
Uddin, MJ ;
Kokubo, S ;
Ueda, K ;
Suenaga, K ;
Uemura, D .
JOURNAL OF NATURAL PRODUCTS, 2001, 64 (09) :1169-1173
[87]   Baicalin induces apoptosis via mitochondrial pathway as prooxidant [J].
Ueda, S ;
Nakamura, H ;
Masutani, H ;
Sasada, T ;
Takabayashi, A ;
Yamaoka, Y ;
Yodoi, J .
MOLECULAR IMMUNOLOGY, 2002, 38 (10) :781-791
[88]  
Vandepapeliere P, 2007, PCT Int. Appl. WO, Patent No. 2007068907
[89]   Vinflunine in Platinum-Pretreated Patients With Locally Advanced or Metastatic Urothelial Carcinoma Results of a Large Phase 2 Study [J].
Vaughn, David J. ;
Srinivas, Sandy ;
Stadler, Walter M. ;
Pili, Roberto ;
Petrylak, Daniel ;
Sternberg, Cora N. ;
Smith, David C. ;
Ringuette, Sarah ;
de Wit, Edwin ;
Pautret, Virginie ;
George, Claude .
CANCER, 2009, 115 (18) :4110-4117
[90]   Polyphenols and Human Health: Prevention of Disease and Mechanisms of Action [J].
Vauzour, David ;
Rodriguez-Mateos, Ana ;
Corona, Giulia ;
Oruna-Concha, Maria Jose ;
Spencer, Jeremy P. E. .
NUTRIENTS, 2010, 2 (11) :1106-1131